Press release
Clinical Oncology Next Generation Sequencing Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033
The Business Research Company recently released a comprehensive report on the Global Clinical Oncology Next Generation Sequencing Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The clinical oncology next generation sequencing market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.52 billion in 2024 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to genomic research advances, cancer biomarker discovery, technological advancements, regulatory approvals.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report
Market Drivers and Trends:
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the clinical oncology next-generation sequencing market during the forecast period. According to the American Cancer Society, there were 1.9 million new cases and 0.6 million cancer deaths in 2021 in the USA. The four most common types of cancer worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the growth of the clinical oncology next-generation sequencing market.
Major companies operating in the clinical oncology next-generation sequencing market are innovating new products such as BenchMark ULTRA PLUS system to increase their profitability in the market. The BenchMark ULTRA PLUS System is a valuable tool for clinical laboratories, particularly those involved in cancer diagnostics and research, as it helps ensure the accuracy and efficiency of diagnostic tests, thereby contributing to improved patient care. For instance, in June 2022, Roche, a Switzerland-based pharmaceutical company, launched the BenchMark ULTRA PLUS system, its most cutting-edge platform for tissue staining. It helps clinicians to decide on a patient's course of therapy in a timely manner, the system offers speedy and accurate test results.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp
Major Key Players of the Market:
Thermo Fisher Scientific; Oxford Nanopore Technologies Ltd.; QIAGEN N.V.; Myriad Genetics Inc.; Illumina Inc.; F. Hoffmann-La Roche Ltd.; PerkinElmer Inc.; Agilent Technologies Inc.; Pacific Biosciences of California Inc.; Caris Life Sciences; Paradigm Diagnostics; GATC Biotech AG; Macrogen Inc.; DNASTAR Inc.; Exosome Diagnostics Inc.; Biomatters Ltd.; Partek Inc.; Foundation Medicine Inc.; Becton Dickinson and Company (BD); Takara Bio Inc.; Creative Biolabs; Mogene LC; Knome Inc.; Genomatix Software GmbH; CLC bio; GnuBIO Inc.; Bio-Rad Laboratories Inc.; BGI Genomics Co. Ltd.; Guardant Health Inc.; Invitae Corporation; Natera Inc.; NeoGenomics Laboratories Inc.; Sysmex Corporation; Veracyte Inc.; Zymo Research Corporation; ArcherDX Inc.; Cepheid; Karius Inc.; OncoDNA S.A.; Personal Genome Diagnostics Inc.; PierianDx Inc.
Clinical Oncology Next Generation Sequencing Market 2024 Key Insights:
• The clinical oncology next generation sequencing market size is expected to grow to $0.86 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%.
• Cancer Incidence And Its Impact On The Clinical Oncology Next-Generation Sequencing Market
• Innovative Products Driving Profitability In The Clinical Oncology Next-Generation Sequencing Market
• North America was the largest region in the clinical oncology next-generation sequencing market in 2023.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13061&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Oncology Next Generation Sequencing Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3669250 • Views: …
More Releases from The Business research company
Leading Companies Advancing Innovation and Growth in the Reusable Rocket Market
The reusable rocket market is gaining remarkable momentum as innovations and growing commercial interest drive its expansion. With increasing adoption by satellite operators and advances in technology, this sector is set to experience substantial growth by 2030. Let's explore the current market size, key players, emerging trends, and how the industry is shaping up for the future.
Projected Market Growth for Reusable Rockets by 2030
The reusable rocket market is anticipated…
Analysis of Segments and Major Growth Areas in the Rapid Prototyping Market for …
The aerospace and defense sectors are increasingly relying on rapid prototyping technologies to accelerate innovation and improve efficiency. This market is gaining momentum, driven by advancements in manufacturing methods and growing demands for high-precision components. Let's explore the current market valuation, key players, emerging trends, and major segments shaping the rapid prototyping industry within aerospace and defense.
Projected Market Growth and Size in Rapid Prototyping for Aerospace and Defense
The rapid…
Key Strategic Developments and Emerging Changes Shaping the Radar System Market …
The radar system market is on track for significant expansion as it adapts to technological advances and growing demand across various sectors. With the increasing integration of cutting-edge radar solutions in both commercial and defense applications, this industry is poised for notable growth through 2030. Let's explore the current market size, key drivers, major players, emerging trends, and segment dynamics shaping this evolving field.
Projected Growth and Market Size Outlook for…
Outlook on the Police Riot Equipment Market: Major Segments, Strategic Developme …
The police riot equipment market is set for significant growth in the coming years, driven by technological advancements and evolving law enforcement needs. As agencies worldwide seek more effective and adaptable gear, the market is poised to expand steadily through 2030. Let's explore the market's anticipated size, key drivers, notable players, emerging trends, and detailed segmentations.
Anticipated Growth Trajectory of the Police Riot Equipment Market
The police riot equipment market size…
More Releases for Clinical
Miami Clinical Research Sets the Standard for Clinical Trials
Miami Clinical Research, a frontrunner in the world of clinical trials and medical research, has emerged as the prime choice for global corporate pharmaceutical giants. With a deep understanding of the complexities of medical studies, the organization champions the crucial role of research in the evolution of transformative therapeutic interventions.
Miami, FL - Renowned as a first-rate center for professional medical exploration, Miami Clinical Research [https://miamiclinicalresearch.com] boasts state-of-the-art facilities, advanced technologies,…
E-Clinical Solutions Market: Revolutionizing Healthcare and Clinical Trials
Introduction
The e-Clinical solutions market has become a pivotal component of the healthcare and pharmaceutical industries. E-Clinical solutions refer to a set of software, tools, and platforms designed to streamline clinical trials and healthcare management. These solutions include electronic data capture (EDC), clinical trial management systems (CTMS), laboratory information management systems (LIMS), and other integrated tools that improve the efficiency, accuracy, and speed of clinical trials and healthcare services. The primary…
E-Clinical Solutions Market: Revolutionizing Clinical Trials
The e-clinical solutions market has experienced significant growth in recent years, driven by the increasing complexity of clinical trials and the need for efficient, accurate, and compliant data management. E-clinical solutions provide a comprehensive suite of tools and technologies to streamline clinical trial processes, accelerate drug development, and improve patient outcomes.
Market Size and Growth
The global e-clinical solutions market is estimated to be worth billions of dollars, with a significant portion…
Clinical Trials Management System Market Optimizing Clinical Trials: The Crucial …
Clinical Trials Management System Market to reach over USD 5.06 billion by the year 2031- Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical…
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation.
This is the premier interdisciplinary forum for…
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.
The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical…
